2018 Investor Presentation

Investors

Overview

Trulieve is the first and leading medical cannabis company in the state of Florida, the third most populous state in the United States. Its vertically-integrated "seed-to-sale" operation has approximately 55% of the Florida market. With a patient base that grows approximately 10% month-to-month, it is poised for growth in this attractive market. Trulieve boasts over 260 SKUs and is constantly adding new, fresh, and exciting items to its product line. Its widespread dispensary network and large delivery fleet provides important, much-needed access to thousands of patients every day throughout the state. Trulieve is committed to growing its dispensary footprint in the state, constantly identifying new locations that will bring Trulieve closer to patients, allowing many more people to have easier access to the medicine they need. The Company has a target of 44 stores in Florida by the end of 2019, with more growth ahead. Its first mover advantage in the state provides numerous benefits, including brand recognition and media attention. Strong financial performance, driven by sales to a loyal and dedicated group of patients affectionately called Trulievers, positions the company's commitment to continue its pattern of growth.

Read more

Finally, Trulieve is actively expanding outside the state of Florida.The company has already announced purchases of licenses in California, Massachusetts and a dispensary in Connecticut in 2019 and is targeting entry into two additional states by the end of 2019.

Copyright West LLC. Minimum 15 minutes delayed.

Events

Featured Video

Midas Letter, August 2019